{"answer":{"query":"Bosulif","resolved_as":"applications","packages":6,"applications":["NDA203341","NDA217729"],"identity":{"application_numbers":["NDA203341","NDA217729"],"marketing_categories":["NDA"],"labelers":[],"dosage_forms":[{"text":"TABLET, FILM COATED","untrusted":true},{"text":"CAPSULE","untrusted":true}],"marketing_start":{"earliest":"2012-09-04","latest":"2024-01-02","packages_with_a_start_date":6}},"generic_entry":[{"application":"NDA203341","date":"2034-08-28","reading":"upper bound from listed dates, not a forecast","basis":"latest of all listed patent and exclusivity expiries in this Orange Book edition; an upper bound from listed dates only, not a forecast of launch (litigation, settlements, delisting, tentative approvals and 180-day status are not modelled)","driver":{"kind":"patent","ref":"11103497*PED","productNo":"001"},"latest_patent_expiry":"2034-08-28","latest_exclusivity_expiry":"2031-03-26","dated_barriers":36,"undated_barriers":0,"orange_book_edition":"2026-09","patents_listed":4,"exclusivities_listed":4,"fact_id":"815718158e54ebcb299160bc"},{"application":"NDA217729","date":"2034-08-28","reading":"upper bound from listed dates, not a forecast","basis":"latest of all listed patent and exclusivity expiries in this Orange Book edition; an upper bound from listed dates only, not a forecast of launch (litigation, settlements, delisting, tentative approvals and 180-day status are not modelled)","driver":{"kind":"patent","ref":"11103497*PED","productNo":"001"},"latest_patent_expiry":"2034-08-28","latest_exclusivity_expiry":"2031-03-26","dated_barriers":24,"undated_barriers":0,"orange_book_edition":"2026-09","patents_listed":4,"exclusivities_listed":4,"fact_id":"b3a8c1619f6ea4e2b8da99e4"}],"label_history":{"events_total":21,"non_cmc_events":21,"counts_by_class":{"LABELING":17,"EFFICACY":4},"cmc_events":0,"recent_non_cmc_events":[{"application":"NDA203341","submission_no":27,"class_code":"LABELING","class_description":{"text":"Labeling","untrusted":true},"status":"AP","date":"2026-03-02","documents":[{"type":"Letter","date":"2026-03-04","link":{"text":"https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2026/203341Orig1s027ltr.pdf","untrusted":true}},{"type":"Label","date":"2026-03-06","link":{"text":"https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/203341s027lbl.pdf","untrusted":true}}],"fact_id":"536520ba649429a8c97add55"},{"application":"NDA217729","submission_no":2,"class_code":"LABELING","class_description":{"text":"Labeling","untrusted":true},"status":"AP","date":"2026-03-02","documents":[{"type":"Letter","date":"2026-03-04","link":{"text":"https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2026/217729Orig1s002ltr.pdf","untrusted":true}},{"type":"Label","date":"2026-03-06","link":{"text":"https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/217729s002lbl.pdf","untrusted":true}}],"fact_id":"882c60b46b71efd6bb46bf67"},{"application":"NDA203341","submission_no":26,"class_code":"LABELING","class_description":{"text":"Labeling","untrusted":true},"status":"AP","date":"2024-12-03","documents":[{"type":"Letter","date":"2024-12-04","link":{"text":"https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2024/203341Orig1s026ltr.pdf","untrusted":true}},{"type":"Label","date":"2024-12-05","link":{"text":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2024/203341s026lbl.pdf","untrusted":true}}],"fact_id":"214acda78c9a28880dae64a3"},{"application":"NDA217729","submission_no":1,"class_code":"LABELING","class_description":{"text":"Labeling","untrusted":true},"status":"AP","date":"2024-12-03","documents":[{"type":"Letter","date":"2024-12-04","link":{"text":"https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2024/217729Orig1s001ltr.pdf","untrusted":true}},{"type":"Label","date":"2024-12-05","link":{"text":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2024/217729s001lbl.pdf","untrusted":true}}],"fact_id":"c6dd19bcb87d5aac866482ef"},{"application":"NDA203341","submission_no":25,"class_code":"EFFICACY","class_description":{"text":"Efficacy","untrusted":true},"status":"AP","date":"2023-09-26","documents":[{"type":"Label","date":"2023-09-26","link":{"text":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2023/203341s025lbl.pdf","untrusted":true}},{"type":"Letter","date":"2023-09-27","link":{"text":"https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2023/203341Orig1s025ltr.pdf","untrusted":true}}],"fact_id":"4854817f5d84f8a9699e3eb2"}],"note":"a dated list of FDA supplements and their classes, not a reading of what changed in the label"},"substitution":{"products_total":5,"te_code_counts":{"AB":3,"NOT_PROVIDED":2},"marketing_status_counts":{"Prescription":5},"meaning":"raw FDA codes; the therapeutic equivalence code says whether FDA rates a generic as substitutable, and what that means for a given prescription is for a pharmacist or prescriber","products":[{"application":"NDA203341","product_no":"001","te_code":"AB","marketing_status":"Prescription","drug_name":{"text":"BOSULIF","untrusted":true},"form":{"text":"TABLET;ORAL","untrusted":true},"strength":{"text":"EQ 100MG BASE","untrusted":true}},{"application":"NDA203341","product_no":"003","te_code":"AB","marketing_status":"Prescription","drug_name":{"text":"BOSULIF","untrusted":true},"form":{"text":"TABLET;ORAL","untrusted":true},"strength":{"text":"EQ 400MG BASE","untrusted":true}},{"application":"NDA203341","product_no":"002","te_code":"AB","marketing_status":"Prescription","drug_name":{"text":"BOSULIF","untrusted":true},"form":{"text":"TABLET;ORAL","untrusted":true},"strength":{"text":"EQ 500MG BASE","untrusted":true}},{"application":"NDA217729","product_no":"002","te_code":null,"marketing_status":"Prescription","drug_name":{"text":"BOSULIF","untrusted":true},"form":{"text":"CAPSULE;ORAL","untrusted":true},"strength":{"text":"EQ 100MG BASE","untrusted":true}},{"application":"NDA217729","product_no":"001","te_code":null,"marketing_status":"Prescription","drug_name":{"text":"BOSULIF","untrusted":true},"form":{"text":"CAPSULE;ORAL","untrusted":true},"strength":{"text":"EQ 50MG BASE","untrusted":true}}]},"spending":{"reported_under":{"generic":{"text":"Bosutinib","untrusted":true},"brand":{"text":"Bosulif","untrusted":true}},"latest_year":2024,"series":[{"year":2020,"gross_spending_usd":123423994.76,"claims":9620,"beneficiaries":1318,"average_spending_per_claim_usd":12829.937085,"fact_id":"b390adfb14f50514a5405ad0"},{"year":2021,"gross_spending_usd":147656079.87,"claims":11031,"beneficiaries":1495,"average_spending_per_claim_usd":13385.557055,"fact_id":"8aa162070efb44161d72d897"},{"year":2022,"gross_spending_usd":170022054.81,"claims":12137,"beneficiaries":1628,"average_spending_per_claim_usd":14008.573355,"fact_id":"e6ff916a0dfaf6a58d6cc9ec"},{"year":2023,"gross_spending_usd":199137491.12,"claims":12955,"beneficiaries":1732,"average_spending_per_claim_usd":15371.477508,"fact_id":"6e37609a6083450e439ec2e9"},{"year":2024,"gross_spending_usd":235311822.75,"claims":15541,"beneficiaries":1981,"average_spending_per_claim_usd":15141.356589,"fact_id":"fa4b43db59bb3c6d89f69131"}],"rebate_caveat":"CMS's dataset states spending is gross drug cost and does not reflect manufacturers' rebates or other price concessions.","not_a_patient_price":"Spending is the total paid by Medicare, plans and beneficiaries for the drug's claims, not what a patient pays.","meaning":"a drug-level aggregate of Medicare Part D claims for all manufacturers combined; not a formulary, not coverage","source":{"dataset":{"text":"data-year-2024, modified 2026-06-25","untrusted":true},"link":{"text":"https://data.cms.gov/summary-statistics-on-use-and-payments/medicare-medicaid-spending-by-drug/medicare-part-d-spending-by-drug","untrusted":true}}},"orphan_designation":{"ingredients":[{"ingredient":{"text":"bosutinib","untrusted":true},"designation_count":3,"approved_count":3,"recent":[{"designated":"2009-02-24","use":{"text":"Treatment of chronic myelogenous leukemia","untrusted":true},"status":"Designated/Approved","sponsor":{"text":"PF PRISM C.V.","untrusted":true},"approved":true},{"designated":"2009-02-24","use":{"text":"Treatment of chronic myelogenous leukemia","untrusted":true},"status":"Designated/Approved","sponsor":{"text":"PF PRISM C.V.","untrusted":true},"approved":true},{"designated":"2009-02-24","use":{"text":"Treatment of chronic myelogenous leukemia","untrusted":true},"status":"Designated/Approved","sponsor":{"text":"PF PRISM C.V.","untrusted":true},"approved":true}],"read_on":"2026-11-07T12:00:00.000Z","fact_id":"16f755db7def095939d06de0"}],"reading":"a designation is not an approval and not a statement that the drug treats the condition; status is the FDA database's own"},"medicaid_state_utilization":{"year":2025,"states_with_data":8,"all_states_medicaid_reimbursed_usd":8646170.47,"all_states_medicaid_paid_prescriptions":493,"top_states":[{"state":"FL","medicaid_paid_prescriptions":79,"medicaid_reimbursed_usd":1558455.26,"total_reimbursed_usd":1558455.26,"packages":1,"covers":"fee_for_service_only","fact_id":"846588a0b718f850f9143d9b"},{"state":"NC","medicaid_paid_prescriptions":70,"medicaid_reimbursed_usd":1389933.31,"total_reimbursed_usd":1389933.31,"packages":1,"covers":"fee_for_service_only","fact_id":"0208427f36bad7ec9d0ef916"},{"state":"TX","medicaid_paid_prescriptions":75,"medicaid_reimbursed_usd":1279885.72,"total_reimbursed_usd":1279885.72,"packages":1,"covers":"all_record_types","fact_id":"37cf24898cff9fb5ac518aee"},{"state":"IL","medicaid_paid_prescriptions":54,"medicaid_reimbursed_usd":989506.84,"total_reimbursed_usd":989506.84,"packages":1,"covers":"all_record_types","fact_id":"26944988e09fdfa4ca840962"},{"state":"IN","medicaid_paid_prescriptions":62,"medicaid_reimbursed_usd":983790.61,"total_reimbursed_usd":983790.61,"packages":1,"covers":"all_record_types","fact_id":"6ab8784fd4406dc93bbe006d"},{"state":"KY","medicaid_paid_prescriptions":53,"medicaid_reimbursed_usd":961725.9,"total_reimbursed_usd":961725.9,"packages":1,"covers":"fee_for_service_only","fact_id":"5e7f14a31fddd88eb9f2eb4f"},{"state":"AZ","medicaid_paid_prescriptions":53,"medicaid_reimbursed_usd":754648.58,"total_reimbursed_usd":754648.58,"packages":1,"covers":"fee_for_service_only","fact_id":"9d330400ba59b66d381a5fd6"},{"state":"CT","medicaid_paid_prescriptions":47,"medicaid_reimbursed_usd":728224.25,"total_reimbursed_usd":728224.25,"packages":1,"covers":"all_record_types","fact_id":"7bab66d96daf0d5a4598e868"}],"unlabelled_state_code_xx":null,"built_from_facts":8,"facts_fee_for_service_only":4,"older_year_facts_not_used":16,"dataset":"State Drug Utilization Data 2025","read_on":"2026-11-07T22:41:44.201Z","reading":"Medicaid prescriptions and reimbursement by state (CMS State Drug Utilization Data). Reimbursement is before manufacturer rebates: not a net cost, not a patient price. Suppressed managed-care cells make a state figure fee-for-service only. An absent state was suppressed or unreported, not zero.","receipts_note":"a receipt is held for the largest fact behind each state shown; every figure is a sum of the built_from_facts facts, each recomputable from its recorded input hash"}},"receipts":[{"fact_id":"5b7c38301d6fd151b746389d","field":"ndc.listing","entity":"ndc:00069013501"},{"fact_id":"c11b026506d7832cd99fb445","field":"ndc.listing","entity":"ndc:00069013601"},{"fact_id":"54beb86b9c852417c6423598","field":"ndc.listing","entity":"ndc:00069019301"},{"fact_id":"815718158e54ebcb299160bc","field":"drug.generic_entry_earliest","entity":"application:NDA203341"},{"fact_id":"ff93dd83f541322992c41ccd","field":"drug.patent","entity":"application:NDA203341"},{"fact_id":"a2e983c02dc3b2d21a64190d","field":"drug.exclusivity","entity":"application:NDA203341"},{"fact_id":"b3a8c1619f6ea4e2b8da99e4","field":"drug.generic_entry_earliest","entity":"application:NDA217729"},{"fact_id":"646c2941653415faaa16d79e","field":"drug.patent","entity":"application:NDA217729"},{"fact_id":"a638eb3790bc2aff6f306b3b","field":"drug.exclusivity","entity":"application:NDA217729"},{"fact_id":"536520ba649429a8c97add55","field":"drug.label_event","entity":"application:NDA203341"},{"fact_id":"882c60b46b71efd6bb46bf67","field":"drug.label_event","entity":"application:NDA217729"},{"fact_id":"214acda78c9a28880dae64a3","field":"drug.label_event","entity":"application:NDA203341"},{"fact_id":"c6dd19bcb87d5aac866482ef","field":"drug.label_event","entity":"application:NDA217729"},{"fact_id":"4854817f5d84f8a9699e3eb2","field":"drug.label_event","entity":"application:NDA203341"},{"fact_id":"9f2435147a532353e716ea1a","field":"drug.te_code","entity":"application:NDA203341"},{"fact_id":"41316e6cbeb705bc3a9c3d98","field":"drug.marketing_status","entity":"application:NDA203341"},{"fact_id":"4c3d2ff247a294acc44a4d42","field":"drug.te_code","entity":"application:NDA203341"},{"fact_id":"99b197359cbe02c150ad6141","field":"drug.marketing_status","entity":"application:NDA203341"},{"fact_id":"3b86a15d4ff379e6f36e54ce","field":"drug.te_code","entity":"application:NDA203341"},{"fact_id":"bd664ba2f676e351eefc9622","field":"drug.marketing_status","entity":"application:NDA203341"},{"fact_id":"d15ef2166d1c4d25fae1fcb5","field":"drug.marketing_status","entity":"application:NDA217729"},{"fact_id":"3583e8d1b8ffbf89c42c5467","field":"drug.marketing_status","entity":"application:NDA217729"},{"fact_id":"b390adfb14f50514a5405ad0","field":"drug.partd_spending","entity":"drug:bosutinib|bosulif"},{"fact_id":"8aa162070efb44161d72d897","field":"drug.partd_spending","entity":"drug:bosutinib|bosulif"},{"fact_id":"e6ff916a0dfaf6a58d6cc9ec","field":"drug.partd_spending","entity":"drug:bosutinib|bosulif"},{"fact_id":"6e37609a6083450e439ec2e9","field":"drug.partd_spending","entity":"drug:bosutinib|bosulif"},{"fact_id":"fa4b43db59bb3c6d89f69131","field":"drug.partd_spending","entity":"drug:bosutinib|bosulif"},{"fact_id":"16f755db7def095939d06de0","field":"drug.orphan_designation","entity":"drug:bosutinib"},{"fact_id":"846588a0b718f850f9143d9b","field":"ndc.medicaid_state_utilization","entity":"ndc_state:00069019301:FL"},{"fact_id":"0208427f36bad7ec9d0ef916","field":"ndc.medicaid_state_utilization","entity":"ndc_state:00069019301:NC"},{"fact_id":"37cf24898cff9fb5ac518aee","field":"ndc.medicaid_state_utilization","entity":"ndc_state:00069019301:TX"},{"fact_id":"26944988e09fdfa4ca840962","field":"ndc.medicaid_state_utilization","entity":"ndc_state:00069013601:IL"},{"fact_id":"6ab8784fd4406dc93bbe006d","field":"ndc.medicaid_state_utilization","entity":"ndc_state:00069013501:IN"},{"fact_id":"5e7f14a31fddd88eb9f2eb4f","field":"ndc.medicaid_state_utilization","entity":"ndc_state:00069019301:KY"},{"fact_id":"9d330400ba59b66d381a5fd6","field":"ndc.medicaid_state_utilization","entity":"ndc_state:00069013501:AZ"},{"fact_id":"7bab66d96daf0d5a4598e868","field":"ndc.medicaid_state_utilization","entity":"ndc_state:00069013501:CT"}],"as_of":{"newest_fact_retrieved_at":"2026-11-10T20:02:39.475Z"},"edition":{"id":"2026-11","merkleRoot":"006ab9a329709cbe7f56a0e1a7c4a02f897655cdfecf9ca34d199690095adcb6","factCount":212100,"manifestPresent":true},"licence":{"classes":["GREEN"],"note":"Source records are public; this compilation is cited with attribution. See the provenance tool for each fact's licence label."},"unknown":[{"code":"NO_DATA","field":"price","reason":"no NADAC price, negotiated price or federal upper limit for these packages"},{"code":"NO_DATA","field":"recalls","reason":"no FDA enforcement report naming a package of these applications is recorded"},{"code":"NO_DATA","field":"supply","reason":"no FDA shortage row and no termination date for these packages"},{"code":"NO_DATA","field":"trials","reason":"no ClinicalTrials.gov record set for this drug's ingredient is in the edition"},{"code":"NO_DATA","field":"assistance_and_offers","reason":"no assistance program lists this drug and no manufacturer offer naming it is recorded; that does not mean none exists"},{"code":"NO_DATA","field":"policy","reason":"no Federal Register event in the edition names this drug or its programs"},{"code":"NO_DATA","field":"biologic_status","reason":"no biologic application of this drug has a Purple Book status in the edition (a drug that is not a biologic has none)"},{"code":"NO_DATA","field":"payment_limit","reason":"no HCPCS code whose NDC crosswalk names a package of these applications has a Part B payment limit in the edition"},{"code":"NO_DATA","field":"rems","reason":"no REMS@FDA program is tied to these applications in the edition (most drugs have none)"},{"code":"NO_DATA","field":"controlled_schedule","reason":"no DEA schedule entry matched this drug's ingredient in the edition"},{"code":"NO_DATA","field":"safety_communication","reason":"no FDA Drug Safety Communication names this drug's ingredient in the edition"}],"disclaimer":"OmniRx is a reference layer of dated public facts, not clinical advice and not a guarantee of price, coverage or eligibility. Each answer lists the facts it rests on."}